Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy

Obesity

Volumn 21, Issue 3, 2013, Pages

  Doesch, Christina ^a   Streitner, Florian ^a   Bellm, Steven ^a   Suselbeck, Tim ^a   Haghi, Dariusch ^a   Heggemann, Felix ^a   Schoenberg, Stefan O ^a   Michaely, Henrik ^a   Borggrefe, Martin ^a   Papavassiliu, Theano ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM PENTETATE MEGLUMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADIPOSE TISSUE; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPICARDIUM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT;

ADIPOSE TISSUE; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; GADOLINIUM; HEART; HEART FAILURE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84876469500     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20149     Document Type: Article

References (41)

1. Richardson PJ,. Assessment of myocardial damage in dilated cardiomyopathy. Eur Heart J 1996; 17: 489-490.
2. Schaper J, Mollnau H, Hein S, et al. Interactions between cardiomyocytes and extracellular matrix in the failing human heart. Z Kardiol 1995; 84 Suppl 4: 33-38.
3. Gunja-Smith Z, Morales AR, Romanelli R, et al. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 1996; 148: 1639-1648.
4. Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251-255.
5. Kremen J, Dolinkova M, Krajickova J, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91: 4620-4627.
6. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
7. Alexopoulos N, McLean DS, Janik M, et al. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210: 150-154.
8. Fantuzzi G, Mazzone T,. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27: 996-1003.
9. Doesch C, Haghi D, Fluchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson 2010; 12: 40.
10. Doesch C, Suselbeck T, Leweling H, et al. Bioimpedance analysis parameters and epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure. Obesity (Silver Spring) 2010; 18: 2326-2332.
11. Khawaja T, Greer C, Chokshi A, et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 2011; 108: 397-401.
12. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-42.
13. Papavassiliu T, Kuhl HP, Schroder M, et al. Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology 2005; 236: 57-64.
14. Hudsmith LE, Petersen SE, Francis JM, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005; 7: 775-782.
15. De Castro S, Caselli S, Maron M, et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart 2007; 93: 205-209.
16. Ghali JK, Liao Y, Cooper RS,. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 1998; 31: 1635-1640.
17. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
18. Nelson AJ, Worthley MI, Psaltis PJ, et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson 2009; 11: 15.
19. Fluchter S, Haghi D, Dinter D, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring) 2007; 15: 870-878.
20. Lehrke S, Lossnitzer D, Schob M, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 727-732.
21. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414-2421.
22. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985.
23. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
24. Iacobellis G, Corradi D, Sharma AM,. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
25. Fruhbeck, G., The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 197-208.
26. Yudkin JS, Eringa E, Stehouwer CD,. «Vasocrine» signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-1820.
27. Iacobellis G, Barbaro, G., The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 2008; 40: 442-445.
28. Iacobellis G, Sharma AM,. Obesity and the heart: redefinition of the relationship. Obes Rev 2007; 8: 35-39.
29. Ahn SG, Lim HS, Joe DY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008; 94: e7.
30. Eroglu S, Sade LE, Yildirir A, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 19: 211-217.
31. Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102: 380-385.
32. Benjamin IJ, Schuster EH, Bulkley BH,. Cardiac hypertrophy in idiopathic dilated congestive cardiomyopathy: a clinicopathologic study. Circulation 1981; 64: 442-447.
33. Grossman W, Jones D, McLaurin LP,. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56-64.
34. Corradi D, Maestri R, Callegari S, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004; 13: 313-316.
35. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004; 94: 1084-1087.
36. Hombach V, Merkle N, Torzewski J, et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009; 30: 2011-2018.
37. Hunt SA,. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: e1-e82.
38. Deckers JW, Hare JM, Baughman KL,. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992; 19: 43-47.
39. Kubo N, Morimoto S, Hiramitsu S, et al. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy. Heart Vessels 1997; 12: 167-170.
40. Gronemeyer SA, Steen RG, Kauffman WM, et al. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging, 2000; 18: 815-818.
41. Machann J, Thamer C, Schnoedt B, et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 2005; 21: 455-462.